从"精神雾"到后急性COVID-19综合征的执行功能改变:对临床方法的影响
Stefano Pallanti1, Michele Di Ponzio2, Gioele Gavazzi3
1Department of Psychiatry and Behavioural Science, Albert Einstein College of Medicine, Bronx, USA; Istituto di Neuroscienze, Florence, Italy.
Journal of psychiatric research
|October 7, 2023
概括
后急性COVID-19综合征 (PACS) 脑雾与像Interleukin-6这样的炎症标志物升高有关. 这种免疫炎症过程与执行功能受损有关,这表明神经PACS的独特亚型.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 后急性COVID-19综合征 (PACS) 通常包括"脑雾",其特点是注意力,记忆力和疲劳问题.
- 脑雾影响9-55%的个体在SARS-CoV-2感染后几个月.
- 对PACS脑雾的神经炎症假设需要进一步验证.
研究的目的:
- 为了研究血液炎症标志物和PACS患者的执行功能之间的联系.
- 为了探索经历神经PACS的患者的免疫-炎症概况.
主要方法:
- 通过Trail Making Test (TMT) A和B部分以及Barkley deficits in Executive Functioning Scale (BDEFS) 对执行职能进行评估.
- 分析了71名PACS患者的炎症和免疫血型.
- 检查了执行功能得分和特定血液炎症标志物之间的相关性.
主要成果:
- 执行功能受损 (BDEFS和TMT B分数) 与增加的IN-6 (IL-6),纤维素和费里丁水平相关.
- 在PACS患者中观察到IL-6,纤维原,费里丁,瘤缩因子-α和C-反应蛋白的水平升高.
- 研究结果表明,PACS中的免疫-炎症过程与执行功能下降有关.
结论:
- PACS的特点是免疫-炎症过程与执行功能减少有关.
- 这项研究支持定义与执行功能改变相关的PACS亚型,超越了"大脑雾"一词.
- 结果对神经PACS的临床管理和预防策略有影响.
相关概念视频
01:30Cognitive Development During Adulthood
129
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
129
01:14Role of Cerebellum and Prefrontal Cortex in Memory
454
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
454
01:28Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
01:26Alzheimer's Disease: Overview
506
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
506
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
136
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
136
01:30Negative and Cognitive Symptoms of Schizophrenia
54
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
54